Ajay Piramal

Piramal and TPG are jointly working with an adviser on divesting a combined 30% stake in the holding company of Shriram General Insurance Ltd., said the people, who asked not to be identified as the information is private. Shriram General Insurance Holdings could be valued at more than $2 billion in a transaction, the people said.

Retail loans key for Piramal Enterprises NBFC arm’s sustained growth ambitions: Experts

While the NBFC was able to lower share of wholesale loans to 64 per cent as on March end from 88 per cent last year, it reported a net loss of Rs 321 crore during Q4FY22 on account of higher provisions made for stressed non-real estate wholesale loans.

Pharma businesses with strong quality compliance to emerge stronger as pandemic impact decreases: Ajay Piramal

The company's pharma vertical is expected to have nearly 15 per cent CAGR revenue growth across businesses in the medium to long-term, Piramal said.

Finding Raza: The science of building an art collection

After Ajay Piramal had experimented with collecting a few works by multiple popular artists, he dove deep into S.H. Raza's work.

ESG as a strategic lever to create long-term sustainable value

Sanjeev Krishan, Chairman, PwC in India, and Koushik Chatterjee, Executive Director and CFO, Tata Steel, were invited for the inaugural episode. To lend the right note to the discussion, Ajay Piramal, Chairman of Piramal Enterprises, made some introductory remarks to share his thoughts highlighting how Piramal Enterprises plans to extend its ESG focus over the next few years and their plans for an ESG fund

Piramal announces demerger of pharmaceuticals business, to create two separate listed entities

"The pharmaceuticals business will get vertically demerged from PEL and consolidated under Piramal Pharma Limited (PPL)," the company announced.

Private equity firm Carlyle to buy a fifth of Piramal Ent's pharma business for nearly $490 million

The transaction values the Piramal Pharma at an enterprise value (EV) of $2.77 billion with an upside component of up to $360 million depending on the company’s FY21 performance.

Exclusive | KKR leads race to buy stake in Piramal's pharma business

The stake-sale process is aimed at raising growth capital and strengthening the Piramal group’s balance sheet.

Piramal Enterprises Q3 profit surges 20% to Rs 724cr

Revenue from operations also rose to Rs 3,805.67 crore for the quarter under review as against Rs 3,489.30 crore in the year-ago period.

Ajay Piramal says will use proceeds of DRG sale to grow financial services biz

"In the NBFC (Non-banking Finance Company) space, many of the NBFCs have actually stopped lending or reduced their lending and therefore this gives us an opportunity to grow organically " said Ajay Piramal.

Piramal partners with Gates Foundation to improve health in India's tribal districts

The new collaborative will focus on improving health and nutrition in high-burden and tribal districts, in support of the Government of India's work to achieve Sustainable Development Goal (SDG) 3 by 2030.

Anand Piramal invests undisclosed amount in Snapdeal

This is the first investment in Snapdeal two years after it rejected its rival Flipkart's offer for an acquisition, and decided to go solo.

Budget 2019 is 'growth-positive', says Ajay Piramal

We welcome the regulations and norms that have been proposed by the FM on the NBFC sector that would raise transparency and reinstate trust in this vital sector

Piramal says only eyeing home loan portfolio of DHFL, not its shares

Piramal has been trying to cut exposure to wholesale real estate lending exposure. The company had reduced lending to real estate from 83 percent in March 2015 to 63 percent in March 2019, and plans to further bring it down to 50 percent by the end of this year.

Ajay Piramal may sell stakes in Shriram group of companies: Report

Ajay Piramal has a 10 percent stake each in public-listed units Shriram Transport Finance and Shriram City Union Finance, and owns 20 percent of Shriram Capital.

Confident Subhash Chandra will meet his debt obligations: Ajay Piramal

Piramal Group has an exposure of Rs 225 crore to Essel, which is covered by collateral.

Piramal Enterprises may consider sale of analytics unit if growth doesn't pick up

Will unlock value if topline and profitability of Decision Resources Group (DRG) doesn't go up significantly, says Ajay Piramal

Piramal considering re-entry into domestic drug market

The development comes eight years after the Ajay Piramal-led conglomerate sold its portfolio to US-based Abbott Laboratories for $3.72 billion.

Big Deal: M&A action in financial services

The financial services space is bursting with transactions but there are many hiccups as well. CNBC-TV18’s Nisha Poddar spoke with Ajay Piramal, Chairman of Piramal Group & Shriram Group about what is brewing at IDFC-Shriram merger. Nisha Poddar also spoke with Abizer Diwanji, Partner, EY India on overall financial space and the mergers and acquisition (M&A) action there.

Shareholders' interests to drive decisions in IDFC-Shriram merger, says Ajay Piramal

One of the biggest financial merger deals in the country, IDFC with Shriram Group, has hit a hurdle after it faced opposition from some of its shareholders.

Piramal Finance announces launch of Piramal Housing Finance

Watch accompanying video of Ajay Piramal, Chairman of Piramal Enterprises addressing a press conference for a strategic announcement.

Infosys to Piramal: How cos spin cash pile for rich returns

Some companies are facing a developed world problem—cash far in excess of their needs. How should investors interpret this?

Piramal to tie-up with CDPQ; will create $250-500mn realty fund

Ajay Piramal group‘s financial services arm Piramal Finance is likely to announce a tie-up with Canada based CDPQ's realty arm for an investment platform.

Piramal Enterprises to demerge healthcare, financial services

In the medium term we will do that. All our acquisitions, and in some ways moving up in value chains and getting more critical mass are steps towards that," Piramal Enterprises Chairman Ajay Piramal told reporters here.

Piramal buys US co's drug portfolio for USD 171 million

Piramal will also pay an additional USD 32 million – depending on financial performance of the acquired assets over the next 3 years.